Mid Atlantic Financial Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$518K Buy
3,118
+193
+7% +$33K 0.03% 441
2021
Q2
$505K Sell
2,925
-5
-0.2% -$826 0.03% 462
2021
Q1
$470K Hold
2,930
0.03% 453
2020
Q4
$492K Buy
2,930
+78
+3% +$12.7K 0.04% 406
2020
Q3
$456K Sell
2,852
-132
-4% -$21.6K 0.04% 385
2020
Q2
$501K Buy
+2,984
New +$468K 0.05% 336
2020
Q1
Sell
-1,402
Closed -$208K 711
2019
Q4
$208K Buy
+1,402
New +$193K 0.02% 634
2019
Q3
Sell
-1,747
Closed -$246K 723
2019
Q2
$246K Buy
1,747
+164
+10% +$22.6K 0.03% 574
2019
Q1
$239K Buy
+1,583
New +$228K 0.03% 576

Other funds holding FBT

Mid Atlantic Financial Management's FBT Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 6.6% in Q3 2021, buying an estimated $33K and bringing the position to 3,118 shares worth $518K. The position accounts for 0.03% of the portfolio, ranked #441.

Mid Atlantic Financial Management first reported a position in FBT in Q1 2019 and has held it in 9 quarters since. 236 funds tracked by Wall St. Rank hold FBT as of Q3 2021.

  • Mid Atlantic Financial Management held 3,118 shares of First Trust NYSE Arca Biotechnology Index Fund worth $518K as of Q3 2021.
  • Mid Atlantic Financial Management bought 193 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2021, an estimated $33K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #441 holding.
  • Mid Atlantic Financial Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 9 quarters since.
  • 236 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.